Roadshow
Transdermal and Transmucosal Delivery System
Apixaban ODF (Oral Dissolving Film) is a thin, fast-dissolving oral formulation of apixaban designed to improve ease of administration and patient compliance, particularly for patients with dysphagia or swallowing difficulties. The film dissolves quickly in the mouth without the need for water, offering a convenient and patient-friendly alternative to conventional tablets while maintaining anticoagulant therapy efficacy.
Join us at BIO 2026, June 22–25 in San Diego!
Taipei’s biotech innovators will showcase cutting-edge solutions and services at the Taiwan Pavilion. Visit Booth #2621 to explore partnership opportunities, meet leading Taipei companies, and discover how Taipei is advancing the future of biotechnology.
Let’s connect at BIO 2026 — see you in San Diego!
#BIO2026 #Taipei #TaiwanPavilion
TAH3311 is TAHO Pharma’s Apixaban Oral Dissolving Film (ODF), developed for anticoagulation therapy in patients with dysphagia or swallowing difficulties. As an innovative oral film formulation for anticoagulant therapy, TAH3311 offers convenient administration without water, improving patient compliance and ease of use. The product demonstrated bioequivalence and comparable safety to Eliquis®.
- #Apixaban
- #Oral Dissolving Film
- #ODF
- #Anticoagulant
- #Dysphagia
- #Stroke Prevention
- #Patient Compliance
- #Transmucosal Delivery
- #Easy Administration
- #Innovative Drug Delivery
- Established 2010
- Company TAHO Pharmaceuticals Ltd
- Telephone +886-2-2659-8515
- Email BD@tahopharma.com
- Address 3F., No. 550, Ruiguang Road, Neihu District, Taipei, 11492, Taiwan
Drug Delivery Technology: